When radioactively labelled vitamin B12 became available after 1950, it was soon established that patients with lesions of the distal small bowel may be unable to absorb normal amounts of vitamin B12 and may develop megaloblastic anaemia.' 2 These observations suggested that ileum is the site of vitamin B12 absorption. Direct evidence was provided in 1959 by Booth and Mollin,3 who studied the distribution of radioactivity in the intestine after oral administration of labelled B 12. Using a Geiger Muller counter during laparotomy, radioactive B12 was found concentrated in the ileum. Vitamin B12 is unique in several respects; it is absorbed only in the ileum in contrast with most other substances; it requires a gastric intrinsic factor to be efficiently absorbed; and because the number of specific receptor sites in the ileum is restricted, only tiny amounts can be absorbed. There is also a delay in the transport from the lumen across the enterocyte until the vitamin appears in the plasma,4 which may be the result of metabolic processes within the enterocyte. In recent years there have been several studies which have enhanced our understanding of vitamin B12 absorption and malabsorption, and the aim of this review is to concentrate on recent developments.
Normal vitamin B12 absorption
Methylcobalamin, deoxyadenosylcobalamin and hydroxycobalamin are the major forms of cobalamin (vitamin B12) in different food sources. The cobalamin used in clinical studies, cyanocobalamin, is an artifact of the isolation procedure. Vitamin B12 cannot be synthesised by mammalian species, but only by microorganisms. In man bacterial synthesis takes place only in the large bowel and the caecum. From these sites absorption cannot take place, and therefore man is entirely dependent on dietary sources of vitamin B12. The richest natural sources are liver and kidney, but vitamin B 12 is also present in meat, fish, dairy products, eggs, and shellfish. The average daily intake is about 3 nmol (4 rig), whereas the physiological needs are 0.4 to 0.8 nmol (0. 5-1.0 itg)
The absorption of vitamin B12 appears to result from an orderly sequence of events. How cobalamins are transported across the enterocyte is not fully understood, and the fate of intrinsic factor is also unclear; intrinsic factor is not absorbed into the blood, and may either be transported into the cell along with vitamin B12, or it may be released at the cell surface. Vitamin B12 is rapidly internalised, and recent experiments in pregnant mice suggest that this occurs by receptor-mediated endocytosis. '' From the ingestion of vitamin B12 until its appearance in the blood there is a delay for several hours.4
This delay appears to be related to the intracellular phase of vitamin B12 absorption. Peters and Hoffbrand'-in Booth's laboratory investigated the intracellular localisation of vitamin B12 during this delay period. After feeding a physiological dose of 7CoBI2 the ileal mucosa of the guinea pig showed a highly significant rise in mitochondrial radioactivity during two hours postfeeding. This activity subsequently decreased coincidentally with a rise in hepatic specific activity. Although this suggests that vitamin B12 is delayed in the mitochondria before the vitamin enters the portal plasma, the metabolic events within the mitochondria during the delay remains to be elucidated.
When vitamin B12 leaves the enterocyte and enters the portal plasma, it is bound to transcobalamin II, but whether binding to transcobalamin 11 occurs within the enterocyte or in the plasma is not clear. Studies in volunteers by Chanarin et 4 In three patients with vitamin B12 malabsorption and pancreatic insufficiency the absorption improved partially with pancreatic extract or sodium bicarbonate or optimally by both. They concluded that the secretion of sodium bicarbonate is required for a suitable pH for the absorption of the vitamin B12-intrinsic factor complex on the intestinal acceptor, and that one or more pancreatic enzymes are essential. showed that incubation of the R-protein-vitamin B12-complex with pancreatic proteases led to rapid release and transfer of vitamin B12 to intrinsic factor; and proposed that the primary defect is lack of pancreatic proteases and a failure to alter R-protein and effect transfer of vitamin B12 to intrinsic factor. Marcoullis et a121 provided in vivo evidence for this hypothesis, and showed that after the administration of 57Co-labelled cyanocobalamin more than 60% of vitamin B12 was bound to R-binders in jejunal fluid from patients with pancreatic insufficiency, whereas all vitamin B12 was bound to intrinsic factor in healthy volunteers.
It is not entirely clear, however, how pancreatic insufficiency leads to vitamin B12 malabsorption. Thus no correlation has been found between pancreatic exocrine function (including faecal fat excretion, trypsin and chymotrypsin secretion) and B12 absorption. 2829 The absorption of vitamin B12 may also be normal in severe pancreatic insufficiency and after total pancreatectomy. Other factors, such as the secretory output of intrinsic factor and R-binders as well as the pH of the stomach might influence whether or not B12 becomes bound to intrinsic factor. Moreover although more than 60% of vitamin B12 was bound by R-protein in the jejunum, in patients with pancreatic insufficiency,27 it is still unknown whether there is an increase in the vitamin B12-Rcomplex in the ileum where vitamin B12 is absorbed.
Although vitamin B12 malabsorption occurs in up to 40-50% of patients with pancreatic insufficiency, vitamin B12 deficiency appears to be rare. This may be related to the unphysiological nature of tests of absorption in the fasting state. Thus Henderson et alobserved that patients who failed to absorb radioactive B12 in the fasting state, had normal absorption when the vitamin was administered together with food. Furthermore the malabsorption may be present only intermittently,28 which might prevent or postpone the development of deficiency.
BACTERIAL OVERGROWTH
In patients with the bacterial overgrowth syndrome or stagnant loop syndrome vitamin B12 malabsorption is associated with a profuse growth of microorganisms in the small intestine; and bacteroides and coliform bacteria are frequently isolated in the highest concentrations. The bacterial flora probably plays an important role for the malabsorption of vitamin B12, as the patients may absorb B12 normally when they are given metronidazole, lincomycin or tetracycline. Booth and Heath3' reported that oral administration of B12 bound to cultures of viable E coli inhibited the absorption of vitamin B12 in the rat. When B12 was bound to organisms killed by heat, the inhibitory effect was abolished; and they proposed that microorganisms in some way interfere with the transport mechanism in the distal small intestine. It is still not clear, however, whether dysfunction of the ileal epithelium plays a role in the malabsorption. The structure of the mucosa is usually normal, and the mucosal enzyme activities have been shown to be similar to those of control patients,32 but Ament et al33 reported a mucosal defect in the absorption of fat in three patients. In the blind loop rat it has been shown that there is unimpaired uptake of vitamin B12 by small intestinal brush borders,34 but so far it is unknown whether there are any disturbances in B12-uptake by the ileal mucosa of patients with bacterial overgrowth.
The most important pathophysiological event appears to be the competive uptake of IF-bound vitamin B12 by bacteria which deprive the host of vitamin B12.
The hypothesis that intestinal bacteria take up intrinsic factor bound vitamin B12 in the intestinal lumen, was investigated by obtaining aspirates from the upper ileum at timed intervals after an oral test meal containing radioactive B12 bound to human intrinsic factor. The proportion of radioactivity in the centrifuged deposits of the ileal aspirates was much higher in patients with the stagnant loop syndrome (43-72%) than in control subjects (0 to 11%).
Presumably the radioactivity in the deposits represented B12 bound by bacteria. Treatment with antibiotics resulted in improved B12 absorption, decreased amount of radioactivity in the ileal deposits, and markedly decreased concentrations of bacteroides. 35 Nevertheless the way in which bacteria interact with vitamin B12 is not clear. Presumably vitamin B12 is bound to intrinsic factor in the lumen of the small intestine. Although most intestinal bacteria avidly take up unbound vitamin B12, the uptake is much reduced if B12 is bound to intrinsic factor in vitro. The inhibitory effect is partial when B12 is bound by rat intrinsic factor,36 whereas pure cultures of bacteroides and coliforms from patients with the stagnant loop syndrome are able to take up In coeliac disease vitamin B12 deficiency is relatively uncommon, and only occurs when the mucosal lesion extends to involve the ileum. Thus a significant correlation was found between epithelial cell height in the ileum and the absorption of vitamin B12. 4 
